Evidence map›Paper›PMID 33385434›Full record

ArticleGastroenterology2021

Ranitidine Use and Cancer Risk: Results From UK Biobank.

Elizabeth D Kantor, Kelli O'Connell, Mengmeng Du, Robin B Mendelsohn, Peter S Liang, Lior Z Braunstein

Abstract read
In one paragraph

Article in Gastroenterology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Anti-Inflammatory Effect ofPlants (Basel, Switzerland) · 2023
    Article
  10. Article
  11. Article
  12. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Elizabeth D KantorDepartment of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York. Electronic address: kantore@mskcc.org.
Kelli O'ConnellDepartment of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
Mengmeng DuDepartment of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
Robin B MendelsohnDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Peter S LiangGastroenterology, Hepatology and Nutrition Service, Department of Medicine, New York University Langone Health, New York, New York; Veterans Affairs New York Harbor Health Care System, New York, New York.
Lior Z BraunsteinDepartment of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York. Electronic address: braunstl@mskcc.org.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Longitudinal Adherence to Colorectal Cancer Screening in the VAK08CA230162 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI LIANG, PETER SHUANG · 2019 to 2023
$1.1M
Medical Research Council MC_PC_17228Medical Research Council MC_QA137853NCI NIH HHS K08 CA230162NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdultAgedFemaleHistamine H2 AntagonistsHumansMaleMiddle AgedNeoplasmsRanitidineRisk AssessmentRisk FactorsTime FactorsUnited KingdomHistamine H2 AntagonistsRanitidineCancerEpidemiologyNDMAOmeprazoleRanitidine

Identifiers

PMID33385434
PMCPMC8035224

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.